(Q42556808)

2 November 2017

Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes (English)

1 reference

2 November 2017

1 reference

S J L Bakker

1

1 reference

2 November 2017

G Navis

series ordinal

2

1 reference

2 November 2017

R O B Gans

series ordinal

3

1 reference

2 November 2017

19 August 2009

1 reference

2 November 2017

1 reference

2 November 2017

52

1 reference

2 November 2017

10

1 reference

2 November 2017

2244

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-009-1495-4

2 November 2017

0 references

cites work

Hematological manifestations of copper deficiency: a retrospective review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744789

PubMed Central

reference URL

Copper deficiency and neurological disorders in man and animals

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744789

PubMed Central

reference URL

A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744789

PubMed Central

reference URL

10.1007/S00125-009-1495-4

16 August 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference

2 November 2017

PubMed publication ID

19690830

1 reference